The litigation process for product liability multidistrict litigation (MDL) No. 2385 is moving steadily forward. U.S. District Judge Robert R. Herndon issued a Case Management Order on January 23, 2014, which identified the first four Pradaxa bleeding injury lawsuits to be heard in court. The... Read More
Boehringer Ingelheim Pharmaceuticals Inc. (BIPI), was fined nearly $1 million for discovery abuse in Pradaxa multidistrict litigation, currently pending in Illinois. U.S. District Judge David R. Herndon, who is overseeing the MDL, said BIPI failing to produce thousands of documents resulted in bad-faith conduct. BIPI,... Read More
Currently, more than 1,500 Pradaxa lawsuits are pending as plaintiffs seek compensation for damages related to internal hemorrhaging from the blood thinning medication. Many of the plaintiff’s claims have been consolidated into a Pradaxa side effects MDL, or multidistrict litigation, and a federal judge who... Read More
For the second year in a row, the controversial anticoagulant Pradaxa leads all other drugs in adverse event reports submitted to the Federal Drug Administration (FDA). According to an analysis by the Institute for Safe Medication Practices (ISMP), in 2012 the FDA Adverse Event Reporting System... Read More
Manufactured by Boehringer Ingelheim, Pradaxa is promoted as a more convenient alternative to its predecessor warfarin for stroke prevention, as the medication entails less rigorous medical monitoring. Despite this convenience, the anticoagulant, which has no known antidote to quell bleeding events, has been linked to... Read More
Plaintiff Joseph Dasaro has filed a Pradaxa gastrointestinal bleeding lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim International GmbH, for personal injuries and wrongful death suffered after the death of his mother, Rose Dasaro, which he alleges was caused by her use of the... Read More
A Pradaxa lawsuit filed in Texas alleges the plaintiff suffered a stroke and internal bleeding due to the drug, an anticoagulant. The complaint, filed against Pradaxa’s manufacturer Boehringer Ingelheim Pharmaceuticals, Inc. (Boehringer), also alleges the defendant produced a dangerous drug, negligently manufactured it, failed to... Read More
